Lorena Infante Lara
-
Alum Answers with Dave Vigerust
For our latest Alum Answers feature, meet Dave Vigerust, PhD’04, who trained as a scientist in Vanderbilt’s IGP umbrella program and then in the Cellular and Molecular Pathology program. He has spent his career interfacing between basic research and the clinic and is now the chief scientific and strategy officer of three companies. Read MoreNov. 20, 2025
-
New technique pioneered at Vanderbilt can identify new risk genes for schizophrenia
Bingshan Li and his lab are changing the paradigm of how geneticists can identify risk genes for schizophrenia, enabling new studies into its underlying biology and opening new doors for the development of treatments against it. Read MoreOct. 29, 2025
-
Vanderbilt scientist tackles key roadblock for AI in drug discovery
Vanderbilt’s Dr. Benjamin P. Brown is improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule. These improvements bring ML closer to fulfilling its potential in the field—something that has not been realized after more than a decade of work. Read MoreOct. 16, 2025
-
Alum Answers with Chase Spurlock
A Middle Tennessee native, Chase Spurlock, PhD’14, was drawn to Vanderbilt University for its excellence in healthcare and science. A project he completed in graduate school ignited in him a desire to impact patient lives through academic-industry partnerships, and he has not looked back since. Read MoreOct. 13, 2025
-
New algorithmic tool can improve microscopy image analysis, making improvements across fields
A new image analysis tool called TrueSpot has the capacity to overhaul the quantity and quality of usable data that can be obtained from fluorescence microscopy, which is used across an enormous range of biological, biomedical, and physical research. Read MoreOct. 6, 2025
-
Vanderbilt research looks to smooth out bumps in medicinal chemistry processes
Vanderbilt researchers probe the mysteries of an enzyme that could be used as a tool in basic research and medicinal chemistry. Read MoreSep. 23, 2025
-
DelGiorno lands prestigious American Cancer Society award to study therapeutic vulnerabilities in pancreatic cancer
Kathleen DelGiorno has received a Research Scholar Award from the American Cancer Society to study pancreatic cancer development. She will focus on the role of two fatty acids that are known to be involved with tumorigenesis. Read MoreSep. 9, 2025
-
Carvajal-García named Destination Biochemistry Advanced Postdoctoral Scholar
Juan Carvajal-García has been named a 2025 Destination Biochemistry Advanced Postdoctoral Scholar, a distinction granted by the Department of Biochemistry at the School of Medicine Basic Sciences. The award will support his transition into an independent research position. Read MoreAug. 18, 2025
-
New research points to lipids as possible culprit in age-related vision loss
Vanderbilt biochemists find role for lipids in age-related vision loss—and pave the way for potential new therapies. Read MoreAug. 14, 2025
-
New research points to cell subtypes that increase risk of diabetes
Recent work from a coalition of Vanderbilt labs has found clear distinctions in insulin-secreting β-cell subtypes and drawn a connection between certain subtypes and a higher risk of diabetes. Read MoreJul. 23, 2025